DANIEL K SPIEGELMAN Insider Trading $CASC Cascadian Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DANIEL K SPIEGELMAN.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DANIEL K SPIEGELMAN. DANIEL K SPIEGELMAN is Senior Vice President and CFO in CV THERAPEUTICS INC ($CVTX) and Director in MYRIAD GENETICS INC ($MYGN) and EVP, Chief Financial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in Oncothyreon Inc. ($ONTY) and Director in Relypsa Inc ($RLYP).

DANIEL K SPIEGELMAN in Cascadian Therapeutics, Inc.

Trading Symbol: CASC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of DANIEL K SPIEGELMAN: Director
Holdings: 0 shares
Latest Transaction: Mar 13 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DANIEL K SPIEGELMAN in Cascadian Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BMRN, CASC, CVTX, MYGN, RLYP

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 13 2018	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Option Exercise	D	0.00	13,927	0	0
Mar 13 2018	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Sell	U	0.00	21,006	0	0	21 K to 0 (-100.00 %)
Sep 26 2017	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Option Exercise	M	0.00	2,375	0	0
Sep 26 2017	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Payment of Exercise	F	3.94	594	2,340	21,006	21.6 K to 21 K (-2.75 %)
Sep 26 2017	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Buy	M	0.00	2,375	0	21,600	19.2 K to 21.6 K (+12.35 %)
Jun 27 2017	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Option Exercise	M	0.00	9,058	0	0
Jun 27 2017	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Payment of Exercise	F	3.78	2,265	8,562	19,225	21.5 K to 19.2 K (-10.54 %)
Jun 27 2017	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Buy	M	0.00	9,058	0	21,490	12.4 K to 21.5 K (+72.86 %)
Jun 13 2017	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Option Exercise	M	0.00	2,148	0	0
Jun 13 2017	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Option Exercise	A	0.00	13,927	0	13,927
Jun 13 2017	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Payment of Exercise	F	3.34	537	1,794	12,432	13 K to 12.4 K (-4.14 %)
Jun 13 2017	CASC	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Buy	M	0.00	2,148	0	12,969	10.8 K to 13 K (+19.85 %)
Jun 28 2016	ONTY	Cascadian Therapeu ...	SPIEGELMAN DANIEL K	Director	Option Exercise	A	0.00	54,347	0	54,347
Sep 28 2015	ONTY	Oncothyreon Inc.	SPIEGELMAN DANIEL K	Director	Option Exercise	A	0.00	14,245	0	14,245
Jun 16 2015	ONTY	Oncothyreon Inc.	SPIEGELMAN DANIEL K	Director	Option Exercise	M	0.00	16,042	0	0
Jun 16 2015	ONTY	Oncothyreon Inc.	SPIEGELMAN DANIEL K	Director	Option Exercise	A	0.00	12,886	0	12,886
Jun 16 2015	ONTY	Oncothyreon Inc.	SPIEGELMAN DANIEL K	Director	Payment of Exercise	F	3.88	4,011	15,563	52,675	56.7 K to 52.7 K (-7.08 %)
Jun 16 2015	ONTY	Oncothyreon Inc.	SPIEGELMAN DANIEL K	Director	Buy	M	0.00	16,042	0	56,686	40.6 K to 56.7 K (+39.47 %)
Apr 01 2015	ONTY	Oncothyreon Inc.	SPIEGELMAN DANIEL K	Director	Buy	P	1.59	10,000	15,856	40,644	30.6 K to 40.6 K (+32.63 %)
Apr 01 2015	ONTY	Oncothyreon Inc.	SPIEGELMAN DANIEL K	Director	Buy	P	1.63	10,000	16,271	30,644	20.6 K to 30.6 K (+48.44 %)

Page: 1